Holocene Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
VPM
VCM
RRAM
Holocene Advisors's HAE Position: Q1 2026 in Review
Holocene Advisors reduced its Haemonetics (HAE) stake by 100% in Q1 2026, selling an estimated $82M and leaving 4,522 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #778.
Holocene Advisors first reported a position in HAE in Q4 2017 and has held it in 17 quarters since. The position peaked at $101M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Holocene Advisors held 4,522 shares of Haemonetics worth $255K as of Q1 2026.
- Holocene Advisors sold 1,259,749 Haemonetics shares in Q1 2026, an estimated $82M.
- Haemonetics made up ﹤0.01% of Holocene Advisors's portfolio in Q1 2026, its #778 holding.
- Holocene Advisors first reported a position in Haemonetics in Q4 2017 and has held it in 17 quarters since.
- Holocene Advisors's Haemonetics position peaked at $101M in Q4 2025.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.